Listed

Bicara Therapeutics Inc.

BCAXNasdaqCIK 2023658HealthcareFiscal year ends Dec 31

Share

Share this page

Story card, 1080 × 1920

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Operating income−$60.0m, Q2 FY2026
Net income−$55.4m, Q2 FY2026
Line itemUnitperiod not labelled2023-09-30period not labelled2023-12-31period not labelled2024-03-31period not labelled2024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Research and development$m6.9Research and development, period not labelled, three months to 2023-09-30$6.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-11-12, accession 0002023658-24-000002.Report this figure10.5Research and development, period not labelled, three months to 2023-12-31$10.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2025-03-27, accession 0002023658-25-000012. Derived: 12-month figure less the 9-month figure.Report this figure12.0Research and development, period not labelled, three months to 2024-03-31$12.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-13, accession 0002023658-25-000039.Report this figure15.8Research and development, period not labelled, three months to 2024-06-30$15.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-08-12, accession 0002023658-25-000098.Report this figure15.9Research and development, Q3 FY2024, three months to 2024-09-30$15.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-10, accession 0002023658-25-000109.Report this figure19.9Research and development, Q4 FY2024, three months to 2024-12-31$19.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2025-03-27, accession 0002023658-25-000012. Derived: 12-month figure less the 9-month figure.Report this figure34.3Research and development, Q1 FY2025, three months to 2025-03-31$34.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-13, accession 0002023658-25-000039.Report this figure24.8Research and development, Q2 FY2025, three months to 2025-06-30$24.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-08-12, accession 0002023658-25-000098.Report this figure33.0Research and development, Q3 FY2025, three months to 2025-09-30$33.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-10, accession 0002023658-25-000109.Report this figurenot reportednot reportednot reported
Operating income$m(9.5)Operating income, period not labelled, three months to 2023-09-30−$9.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-12, accession 0002023658-24-000002.Report this figure(13.7)Operating income, period not labelled, three months to 2023-12-31−$13.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-03-27, accession 0002023658-25-000012. Derived: 12-month figure less the 9-month figure.Report this figure(15.4)Operating income, period not labelled, three months to 2024-03-31−$15.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-13, accession 0002023658-25-000039.Report this figure(19.8)Operating income, period not labelled, three months to 2024-06-30−$19.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-12, accession 0002023658-25-000098.Report this figure(20.6)Operating income, Q3 FY2024, three months to 2024-09-30−$20.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-10, accession 0002023658-25-000109.Report this figure(26.6)Operating income, Q4 FY2024, three months to 2024-12-31−$26.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-30, accession 0001628280-26-022010. Derived: 12-month figure less the 9-month figure.Report this figure(41.8)Operating income, Q1 FY2025, three months to 2025-03-31−$41.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-11, accession 0001628280-26-033429.Report this figure(32.0)Operating income, Q2 FY2025, three months to 2025-06-30−$32.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-11, accession 0001628280-26-055765.Report this figure(40.7)Operating income, Q3 FY2025, three months to 2025-09-30−$40.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-10, accession 0002023658-25-000109.Report this figure(41.1)Operating income, Q4 FY2025, three months to 2025-12-31−$41.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-30, accession 0001628280-26-022010. Derived: 12-month figure less the 9-month figure.Report this figure(60.2)Operating income, Q1 FY2026, three months to 2026-03-31−$60.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-11, accession 0001628280-26-033429.Report this figure(60.0)Operating income, Q2 FY2026, three months to 2026-06-30−$60.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-11, accession 0001628280-26-055765.Report this figure
Income tax$m0.0Income tax, period not labelled, three months to 2023-09-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2024-11-12, accession 0002023658-24-000002.Report this figure0.0Income tax, period not labelled, three months to 2023-12-31$5.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2025-03-27, accession 0002023658-25-000012. Derived: 12-month figure less the 9-month figure.Report this figure0.0Income tax, period not labelled, three months to 2024-03-31$1.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-05-13, accession 0002023658-25-000039.Report this figure0.0Income tax, period not labelled, three months to 2024-06-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-08-12, accession 0002023658-25-000098.Report this figure0.0Income tax, Q3 FY2024, three months to 2024-09-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-10, accession 0002023658-25-000109.Report this figure0.2Income tax, Q4 FY2024, three months to 2024-12-31$186.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-03-30, accession 0001628280-26-022010. Derived: 12-month figure less the 9-month figure.Report this figure0.1Income tax, Q1 FY2025, three months to 2025-03-31$72.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-11, accession 0001628280-26-033429.Report this figure0.1Income tax, Q2 FY2025, three months to 2025-06-30$52.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-11, accession 0001628280-26-055765.Report this figure0.0Income tax, Q3 FY2025, three months to 2025-09-30$40.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-10, accession 0002023658-25-000109.Report this figure0.1Income tax, Q4 FY2025, three months to 2025-12-31$53.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-03-30, accession 0001628280-26-022010. Derived: 12-month figure less the 9-month figure.Report this figure0.1Income tax, Q1 FY2026, three months to 2026-03-31$52.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-11, accession 0001628280-26-033429.Report this figure0.1Income tax, Q2 FY2026, three months to 2026-06-30$61.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-11, accession 0001628280-26-055765.Report this figure
Net income$m(22.8)Net income, period not labelled, three months to 2023-09-30−$22.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-11-12, accession 0002023658-24-000002.Report this figure(12.4)Net income, period not labelled, three months to 2023-12-31−$12.4m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-03-27, accession 0002023658-25-000012. Derived: 12-month figure less the 9-month figure.Report this figure(12.5)Net income, period not labelled, three months to 2024-03-31−$12.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-10, accession 0002023658-25-000109.Report this figure(17.0)Net income, period not labelled, three months to 2024-06-30−$17.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-10, accession 0002023658-25-000109.Report this figure(17.5)Net income, Q3 FY2024, three months to 2024-09-30−$17.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-10, accession 0002023658-25-000109.Report this figure(21.0)Net income, Q4 FY2024, three months to 2024-12-31−$21.0m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-30, accession 0001628280-26-022010. Derived: 12-month figure less the 9-month figure.Report this figure(36.8)Net income, Q1 FY2025, three months to 2025-03-31−$36.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-11, accession 0001628280-26-055765.Report this figure(27.4)Net income, Q2 FY2025, three months to 2025-06-30−$27.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-11, accession 0001628280-26-055765.Report this figure(36.3)Net income, Q3 FY2025, three months to 2025-09-30−$36.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-10, accession 0002023658-25-000109.Report this figure(37.4)Net income, Q4 FY2025, three months to 2025-12-31−$37.4m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-30, accession 0001628280-26-022010. Derived: 12-month figure less the 9-month figure.Report this figure(56.2)Net income, Q1 FY2026, three months to 2026-03-31−$56.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-11, accession 0001628280-26-055765.Report this figure(55.4)Net income, Q2 FY2026, three months to 2026-06-30−$55.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-11, accession 0001628280-26-055765.Report this figure
Diluted EPS$ per share(38.23)Diluted EPS, period not labelled, three months to 2023-09-30−$38.23 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-11-12, accession 0002023658-24-000002.Report this figurenot reported(18.94)Diluted EPS, period not labelled, three months to 2024-03-31−$18.94 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-13, accession 0002023658-25-000039.Report this figure(19.01)Diluted EPS, period not labelled, three months to 2024-06-30−$19.01 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-12, accession 0002023658-25-000098.Report this figure(1.60)Diluted EPS, Q3 FY2024, three months to 2024-09-30−$1.60 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-10, accession 0002023658-25-000109.Report this figurenot reported(0.68)Diluted EPS, Q1 FY2025, three months to 2025-03-31−$0.68 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-11, accession 0001628280-26-033429.Report this figure(0.50)Diluted EPS, Q2 FY2025, three months to 2025-06-30−$0.50 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-11, accession 0001628280-26-055765.Report this figure(0.67)Diluted EPS, Q3 FY2025, three months to 2025-09-30−$0.67 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-10, accession 0002023658-25-000109.Report this figurenot reported(0.93)Diluted EPS, Q1 FY2026, three months to 2026-03-31−$0.93 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-11, accession 0001628280-26-033429.Report this figure(0.82)Diluted EPS, Q2 FY2026, three months to 2026-06-30−$0.82 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-11, accession 0001628280-26-055765.Report this figure
Basic EPS$ per share(38.23)Basic EPS, period not labelled, three months to 2023-09-30−$38.23 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-12, accession 0002023658-24-000002.Report this figurenot reported(18.94)Basic EPS, period not labelled, three months to 2024-03-31−$18.94 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-13, accession 0002023658-25-000039.Report this figure(19.01)Basic EPS, period not labelled, three months to 2024-06-30−$19.01 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-12, accession 0002023658-25-000098.Report this figure(1.60)Basic EPS, Q3 FY2024, three months to 2024-09-30−$1.60 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-10, accession 0002023658-25-000109.Report this figurenot reported(0.68)Basic EPS, Q1 FY2025, three months to 2025-03-31−$0.68 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-11, accession 0001628280-26-033429.Report this figure(0.50)Basic EPS, Q2 FY2025, three months to 2025-06-30−$0.50 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-11, accession 0001628280-26-055765.Report this figure(0.67)Basic EPS, Q3 FY2025, three months to 2025-09-30−$0.67 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-10, accession 0002023658-25-000109.Report this figurenot reported(0.93)Basic EPS, Q1 FY2026, three months to 2026-03-31−$0.93 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-11, accession 0001628280-26-033429.Report this figure(0.82)Basic EPS, Q2 FY2026, three months to 2026-06-30−$0.82 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-11, accession 0001628280-26-055765.Report this figure

Balance sheet

Cash and equivalents$96.6m, Q2 FY2026
Shareholders' equity$468.8m, Q2 FY2026
Line itemUnitperiod not labelled2023-09-30period not labelled2023-12-31period not labelled2024-03-31period not labelled2024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$mnot reported230Cash and equivalents, period not labelled, at 2023-12-31$230.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-03-27, accession 0002023658-25-000012.Report this figurenot reportednot reported521Cash and equivalents, Q3 FY2024, at 2024-09-30$520.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-12, accession 0002023658-24-000002.Report this figure490Cash and equivalents, FY2024, at 2024-12-31$489.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-03-30, accession 0001628280-26-022010.Report this figure462Cash and equivalents, Q1 FY2025, at 2025-03-31$462.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-13, accession 0002023658-25-000039.Report this figure437Cash and equivalents, Q2 FY2025, at 2025-06-30$436.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-12, accession 0002023658-25-000098.Report this figure172Cash and equivalents, Q3 FY2025, at 2025-09-30$171.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-10, accession 0002023658-25-000109.Report this figure96.7Cash and equivalents, FY2025, at 2025-12-31$96.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-11, accession 0001628280-26-055765.Report this figure323Cash and equivalents, Q1 FY2026, at 2026-03-31$323.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-11, accession 0001628280-26-033429.Report this figure96.6Cash and equivalents, Q2 FY2026, at 2026-06-30$96.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-11, accession 0001628280-26-055765.Report this figure
Current assets$mnot reported231Current assets, period not labelled, at 2023-12-31$231.1m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-03-27, accession 0002023658-25-000012.Report this figurenot reportednot reported522Current assets, Q3 FY2024, at 2024-09-30$521.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-12, accession 0002023658-24-000002.Report this figure503Current assets, FY2024, at 2024-12-31$502.5m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-03-30, accession 0001628280-26-022010.Report this figure471Current assets, Q1 FY2025, at 2025-03-31$470.8m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-13, accession 0002023658-25-000039.Report this figure444Current assets, Q2 FY2025, at 2025-06-30$444.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-12, accession 0002023658-25-000098.Report this figure297Current assets, Q3 FY2025, at 2025-09-30$297.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-10, accession 0002023658-25-000109.Report this figure422Current assets, FY2025, at 2025-12-31$422.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-11, accession 0001628280-26-055765.Report this figure545Current assets, Q1 FY2026, at 2026-03-31$544.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-11, accession 0001628280-26-033429.Report this figure504Current assets, Q2 FY2026, at 2026-06-30$503.8m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-11, accession 0001628280-26-055765.Report this figure
Total assets$mnot reported234Total assets, period not labelled, at 2023-12-31$234.0m. XBRL concept us-gaap:Assets. 10-K filed 2025-03-27, accession 0002023658-25-000012.Report this figurenot reportednot reported524Total assets, Q3 FY2024, at 2024-09-30$524.2m. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-12, accession 0002023658-24-000002.Report this figure510Total assets, FY2024, at 2024-12-31$510.0m. XBRL concept us-gaap:Assets. 10-K filed 2026-03-30, accession 0001628280-26-022010.Report this figure478Total assets, Q1 FY2025, at 2025-03-31$478.1m. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-13, accession 0002023658-25-000039.Report this figure454Total assets, Q2 FY2025, at 2025-06-30$453.6m. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-12, accession 0002023658-25-000098.Report this figure425Total assets, Q3 FY2025, at 2025-09-30$424.7m. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-10, accession 0002023658-25-000109.Report this figure431Total assets, FY2025, at 2025-12-31$431.0m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-11, accession 0001628280-26-055765.Report this figure554Total assets, Q1 FY2026, at 2026-03-31$553.6m. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-11, accession 0001628280-26-033429.Report this figure512Total assets, Q2 FY2026, at 2026-06-30$512.2m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-11, accession 0001628280-26-055765.Report this figure
Current liabilities$mnot reported15.1Current liabilities, period not labelled, at 2023-12-31$15.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-03-27, accession 0002023658-25-000012.Report this figurenot reportednot reported14.5Current liabilities, Q3 FY2024, at 2024-09-30$14.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-12, accession 0002023658-24-000002.Report this figure18.0Current liabilities, FY2024, at 2024-12-31$18.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-03-30, accession 0001628280-26-022010.Report this figure19.1Current liabilities, Q1 FY2025, at 2025-03-31$19.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-13, accession 0002023658-25-000039.Report this figure17.2Current liabilities, Q2 FY2025, at 2025-06-30$17.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-12, accession 0002023658-25-000098.Report this figure21.0Current liabilities, Q3 FY2025, at 2025-09-30$21.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-10, accession 0002023658-25-000109.Report this figure28.9Current liabilities, FY2025, at 2025-12-31$28.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-11, accession 0001628280-26-055765.Report this figure39.3Current liabilities, Q1 FY2026, at 2026-03-31$39.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-11, accession 0001628280-26-033429.Report this figure43.5Current liabilities, Q2 FY2026, at 2026-06-30$43.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-11, accession 0001628280-26-055765.Report this figure
Total liabilities$mnot reported15.5Total liabilities, period not labelled, at 2023-12-31$15.5m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-03-27, accession 0002023658-25-000012.Report this figurenot reportednot reported14.6Total liabilities, Q3 FY2024, at 2024-09-30$14.6m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-12, accession 0002023658-24-000002.Report this figure18.1Total liabilities, FY2024, at 2024-12-31$18.1m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-03-30, accession 0001628280-26-022010.Report this figure19.1Total liabilities, Q1 FY2025, at 2025-03-31$19.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-13, accession 0002023658-25-000039.Report this figure18.4Total liabilities, Q2 FY2025, at 2025-06-30$18.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-12, accession 0002023658-25-000098.Report this figure21.9Total liabilities, Q3 FY2025, at 2025-09-30$21.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-10, accession 0002023658-25-000109.Report this figure29.5Total liabilities, FY2025, at 2025-12-31$29.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-11, accession 0001628280-26-055765.Report this figure39.6Total liabilities, Q1 FY2026, at 2026-03-31$39.6m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-11, accession 0001628280-26-033429.Report this figure43.5Total liabilities, Q2 FY2026, at 2026-06-30$43.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-11, accession 0001628280-26-055765.Report this figure
Shareholders' equity$m(137)Shareholders' equity, period not labelled, at 2023-09-30−$137.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-11-12, accession 0002023658-24-000002.Report this figure(149)Shareholders' equity, period not labelled, at 2023-12-31−$148.8m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-03-30, accession 0001628280-26-022010.Report this figure(160)Shareholders' equity, period not labelled, at 2024-03-31−$160.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-10, accession 0002023658-25-000109.Report this figure(175)Shareholders' equity, period not labelled, at 2024-06-30−$174.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-10, accession 0002023658-25-000109.Report this figure510Shareholders' equity, Q3 FY2024, at 2024-09-30$509.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-10, accession 0002023658-25-000109.Report this figure492Shareholders' equity, FY2024, at 2024-12-31$491.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-11, accession 0001628280-26-055765.Report this figure459Shareholders' equity, Q1 FY2025, at 2025-03-31$459.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-11, accession 0001628280-26-055765.Report this figure435Shareholders' equity, Q2 FY2025, at 2025-06-30$435.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-11, accession 0001628280-26-055765.Report this figure403Shareholders' equity, Q3 FY2025, at 2025-09-30$402.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-10, accession 0002023658-25-000109.Report this figure401Shareholders' equity, FY2025, at 2025-12-31$401.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-11, accession 0001628280-26-055765.Report this figure514Shareholders' equity, Q1 FY2026, at 2026-03-31$514.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-11, accession 0001628280-26-055765.Report this figure469Shareholders' equity, Q2 FY2026, at 2026-06-30$468.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-11, accession 0001628280-26-055765.Report this figure

Cash flow

Operating cash flow−$44.2m, Q2 FY2026
Capital expenditure$60.0k, Q2 FY2026
Line itemUnitperiod not labelled2023-12-31period not labelled2024-03-31period not labelled2024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$m(8.0)Operating cash flow, period not labelled, three months to 2023-12-31−$8.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-03-27, accession 0002023658-25-000012. Derived: 12-month figure less the 9-month figure.Report this figure(14.6)Operating cash flow, period not labelled, three months to 2024-03-31−$14.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-13, accession 0002023658-25-000039.Report this figure(12.9)Operating cash flow, period not labelled, three months to 2024-06-30−$12.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-12, accession 0002023658-25-000098. Derived: 6-month figure less the 3-month figure.Report this figure(17.2)Operating cash flow, Q3 FY2024, three months to 2024-09-30−$17.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-10, accession 0002023658-25-000109. Derived: 9-month figure less the 6-month figure.Report this figure(30.0)Operating cash flow, Q4 FY2024, three months to 2024-12-31−$30.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-30, accession 0001628280-26-022010. Derived: 12-month figure less the 9-month figure.Report this figure(28.1)Operating cash flow, Q1 FY2025, three months to 2025-03-31−$28.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-11, accession 0001628280-26-033429.Report this figure(25.6)Operating cash flow, Q2 FY2025, three months to 2025-06-30−$25.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-11, accession 0001628280-26-055765. Derived: 6-month figure less the 3-month figure.Report this figure(29.2)Operating cash flow, Q3 FY2025, three months to 2025-09-30−$29.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-10, accession 0002023658-25-000109. Derived: 9-month figure less the 6-month figure.Report this figure(23.9)Operating cash flow, Q4 FY2025, three months to 2025-12-31−$23.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-30, accession 0001628280-26-022010. Derived: 12-month figure less the 9-month figure.Report this figure(37.5)Operating cash flow, Q1 FY2026, three months to 2026-03-31−$37.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-11, accession 0001628280-26-033429.Report this figure(44.2)Operating cash flow, Q2 FY2026, three months to 2026-06-30−$44.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-11, accession 0001628280-26-055765. Derived: 6-month figure less the 3-month figure.Report this figure
Capital expenditure$m0.4Capital expenditure, period not labelled, three months to 2023-12-31$436.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2025-03-27, accession 0002023658-25-000012. Derived: 12-month figure less the 9-month figure.Report this figure0.0Capital expenditure, period not labelled, three months to 2024-03-31$4.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-05-13, accession 0002023658-25-000039.Report this figure0.0Capital expenditure, period not labelled, three months to 2024-06-30$19.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-08-12, accession 0002023658-25-000098. Derived: 6-month figure less the 3-month figure.Report this figure0.0Capital expenditure, Q3 FY2024, three months to 2024-09-30$8.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-10, accession 0002023658-25-000109. Derived: 9-month figure less the 6-month figure.Report this figure0.0Capital expenditure, Q4 FY2024, three months to 2024-12-31$40.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-30, accession 0001628280-26-022010. Derived: 12-month figure less the 9-month figure.Report this figure0.0Capital expenditure, Q1 FY2025, three months to 2025-03-31$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-11, accession 0001628280-26-033429.Report this figure0.0Capital expenditure, Q2 FY2025, three months to 2025-06-30$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-11, accession 0001628280-26-055765. Derived: 6-month figure less the 3-month figure.Report this figure0.0Capital expenditure, Q3 FY2025, three months to 2025-09-30$42.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-10, accession 0002023658-25-000109. Derived: 9-month figure less the 6-month figure.Report this figure0.2Capital expenditure, Q4 FY2025, three months to 2025-12-31$238.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-30, accession 0001628280-26-022010. Derived: 12-month figure less the 9-month figure.Report this figure0.1Capital expenditure, Q1 FY2026, three months to 2026-03-31$60.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-11, accession 0001628280-26-033429.Report this figure0.1Capital expenditure, Q2 FY2026, three months to 2026-06-30$60.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-11, accession 0001628280-26-055765. Derived: 6-month figure less the 3-month figure.Report this figure

Shares

Diluted shares (weighted)67.93m, Q2 FY2026
Line itemUnitperiod not labelled2023-09-30period not labelled2024-03-31period not labelled2024-06-30Q3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Diluted shares (weighted)m shares0.6Diluted shares (weighted), period not labelled, three months to 2023-09-30597,586 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-11-12, accession 0002023658-24-000002.Report this figure0.7Diluted shares (weighted), period not labelled, three months to 2024-03-31660,288 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-13, accession 0002023658-25-000039.Report this figure0.9Diluted shares (weighted), period not labelled, three months to 2024-06-30896,744 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-08-12, accession 0002023658-25-000098.Report this figure10.9Diluted shares (weighted), Q3 FY2024, three months to 2024-09-3010,901,138 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-10, accession 0002023658-25-000109.Report this figure54.5Diluted shares (weighted), Q1 FY2025, three months to 2025-03-3154,456,515 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-11, accession 0001628280-26-033429.Report this figure54.5Diluted shares (weighted), Q2 FY2025, three months to 2025-06-3054,539,230 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-11, accession 0001628280-26-055765.Report this figure54.6Diluted shares (weighted), Q3 FY2025, three months to 2025-09-3054,563,864 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-10, accession 0002023658-25-000109.Report this figure60.7Diluted shares (weighted), Q1 FY2026, three months to 2026-03-3160,717,041 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-11, accession 0001628280-26-033429.Report this figure67.9Diluted shares (weighted), Q2 FY2026, three months to 2026-06-3067,925,963 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-11, accession 0001628280-26-055765.Report this figure

Shares outstanding: 66.17mShares outstanding, period not labelled, at 2026-08-0666,172,934 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-08-11, accession 0001628280-26-055765.Report this figure at Aug 6, 2026, from the cover of the 10-Q filed Aug 11, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:50 ET. Listed shows no prices and gives no investment advice.